CRYO-CELL International, Inc. (A:CCEL)

Business Focus: Healthcare Facilities & Services

Sector:  Healthcare Industry:  Healthcare Facilities & Services
 
See Regulatory Filings on SEC
Company Contact
Address: 700 BROOKER CREEK BLVD, SUITE 1800
OLDSMAR FL 34677
Tel: 1-813-7492102
Website: https://www.cryo-cell.com
IR: See website
<
Key People
David I. Portnoy
Chairman of the Board, Co-Chief Executive Officer
Mark L. Portnoy
Co-Chief Executive Officer, Director
Jill M. Taymans
Chief Financial Officer, Vice President - Finance
Oleg Mikulinsky
Chief Information Officer
Joanne Kurtzberg
Medical Director
 
Business Overview
Cryo-Cell International, Inc. is a cord blood banking company. The Company operates through three segments: cellular processing and cryogenic storage for family use, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells; manufacture of PrepaCyte CB Processing System (PrepaCyte CB) units, the processing technology used to process umbilical cord blood stem cells, and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The Company stores approximately 235,000 cord blood and cord tissue specimens. The specimens are stored in commercially available cryogenic storage units at its technologically and operationally advanced facility. The Company markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals.
Financial Overview
For the three months ended 29 February 2024, CRYO-CELL International, Inc. revenues increased less than 1% to $7.9M. Net income decreased 27% to $556K. Revenues reflect Umbilical cord blood and cord tissue stem cell service segment increase of 3% to $7.8M, also reflect Public cord blood banking segment decrease of 81% to $44K, Prepacyte CB segment decrease of 91% to $3K.
Employees: 82 as of Nov 30, 2023
Reporting Currency: U.S. Dollars
Enterprise value: $79.71M as of Feb 29, 2024
Annual revenue (TTM): $31.37M as of Feb 29, 2024
EBITDA (TTM): $4.80M as of Feb 29, 2024
Net annual income (TTM): -$9.73M as of Feb 29, 2024
Free cash flow (TTM): -$0.00M as of Feb 29, 2024
Net Debt Last Fiscal Year: $7.58M as of Feb 29, 2024
Shares outstanding: 8,104,477 as of Apr 15, 2024
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.